Merck Keeps Patent Over Cancer Drug Keytruda
Merck has won its bid to amend a patent over its blockbuster cancer-treating drug Keytruda, after European officials ruled that its stabilizing features for long-term refrigeration were inventive....To view the full article, register now.
Already a subscriber? Click here to view full article